Aridis Pharmaceuticals Inc (ARDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2006 | 12-2005 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 25,096 | N/A | N/A |
| TOTAL | $25,340 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 750 | N/A | N/A |
| Intangibles | 43 | 0 | 0 |
| Other Non-Current Assets | 345 | 0 | 0 |
| TOTAL | $1,138 | $N/A | $N/A |
| Total Assets | $26,478 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 933 | 0 | 0 |
| Accrued Expenses | 2,121 | N/A | N/A |
| TOTAL | $3,174 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Deferred Revenues | 120 | N/A | N/A |
| Other Non-Current Liabilities | 11,868 | 0 | 0 |
| TOTAL | $11,868 | $N/A | $N/A |
| Total Liabilities | $15,042 | $N/A | $N/A |
| Shareholders' Equity | |||
| Retained earnings | -47,626 | N/A | N/A |
| Other shareholders' equity | 74,202 | 0 | 0 |
| TOTAL | $11,436 | $N/A | $N/A |
| Total Liabilities And Equity | $26,478 | $0 | $0 |